Biote Quote - BTMD

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.03

Bid

6.00

Offer

6.68

Volume

90,407

6.00 Day's Range 6.36

3.6538 52 Week Range 8.44

Market Cap

327.653M

Previous Close

6.18

Open

6.18

Last Trade

6.0001

Last Trade Time

Financial Volume

US$ 552,535

VWAP

6.1116

Average Volume (3m)

141,709

Shares Outstanding

54,337,138

Dividend Yield

PE Ratio

98.85

Earnings Per Share (EPS)

0.06

Revenue

185.36M

Net Profit

3.32M

Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business.

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Website

www.biote.com

Headquarters

Wilmington, Delaware, USA

Founded

Biote Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker BTMD. The last closing price for Biote was US$6.18. Over the last year, Biote shares have traded in a share price range of US$ 3.6538 to US$ 8.44.

Biote currently has 54,337,138 shares in issue. The market capitalisation of Biote is US$335.80 million. Biote has a price to earnings ratio (PE ratio) of 98.85.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Biote Reports Third Quarter 2024 Financial Results

Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages Biote...

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Second Quarter 2024 Financial Results

Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance Biote (NASDAQ: BTMD), a leading solutions...

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports First Quarter 2024 Financial Results

Procedure revenue growth and strengthened profitability drive solid financial performance Phased launch of BioteRx remains on track Reaffirms 2024 financial guidance, with an acceleration in...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.12	2.03045685279	5.91	6.32	5.7582	87636	6.10279852	CS
4	-0.49	-7.51533742331	6.52	6.9	5.68	120976	6.2724886	CS
12	0.84	16.1849710983	5.19	6.98	5.005	141709	5.98981503	CS
26	-1.37	-18.5135135135	7.4	8.44	4.935	169508	6.34764035	CS
52	1.11	22.5609756098	4.92	8.44	3.6538	168590	6.25767028	CS
156	-4.01	-39.9402390438	10.04	10.51	2.75	126311	5.7597327	CS
260	-4.01	-39.9402390438	10.04	10.51	2.75	126311	5.7597327	CS

BTMD - Frequently Asked Questions (FAQ)

What is the current Biote share price?

The current share price of Biote is US$ 6.03

How many Biote shares are in issue?

Biote has 54,337,138 shares in issue

What is the market cap of Biote?

The market capitalisation of Biote is USD 335.8M

What is the 1 year trading range for Biote share price?

Biote has traded in the range of US$ 3.6538 to US$ 8.44 during the past year

What is the PE ratio of Biote?

The price to earnings ratio of Biote is 98.85

What is the cash to sales ratio of Biote?

The cash to sales ratio of Biote is 1.77

What is the reporting currency for Biote?

Biote reports financial results in USD

What is the latest annual turnover for Biote?

The latest annual turnover of Biote is USD 185.36M

What is the latest annual profit for Biote?

The latest annual profit of Biote is USD 3.32M

What is the registered address of Biote?

The registered address for Biote is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Biote website address?

The website address for Biote is www.biote.com

Which industry sector does Biote operate in?

Biote operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONCBeiGene Ltd	184.21 (731.65%)	132.21k
RAINRain Enhancement Technologies Holdco Inc	6.75 (457.85%)	211.35k
NITON2OFF Inc	US$ 1.07 (331.45%)	603.87M
CTCXCarmell Corporation	US$ 0.6991 (150.48%)	314.15M
TXMDTherapeuticsMD Inc	US$ 1.58 (83.72%)	7.41M
NMRANeumora Therapeutics Inc	US$ 1.965 (-81.46%)	44.29M
THCHTH International Limited	US$ 0.71 (-80.00%)	46.39k
MARXMars Acquisition Corporation	US$ 2.47 (-73.58%)	1.19M
SISIShineco Inc	US$ 2.07 (-54.30%)	1.73M
MARXUMars Acquisition Corporation	US$ 6.23 (-40.10%)	66.1k
NITON2OFF Inc	US$ 1.07 (331.45%)	603.55M
MBIOMustang Bio Inc	US$ 0.2093 (18.25%)	310.88M
CTCXCarmell Corporation	US$ 0.6991 (150.48%)	309.04M
CGBSCrown LNG Holdings Ltd	US$ 0.6749 (68.68%)	278.33M
SVMHSRIVARU Holding Ltd	US$ 0.0599 (42.28%)	275.21M